Breaking News

Bayer Drops Out in the Race for Schiff

November 20, 2012

According to published reports, Bayer AG has ceased its pursuit of Schiff Nutrition International Inc., ending speculation that the deal was poised to become the industry’s most expensive acquisition.

Late last month German drugmaker Bayer announced its intent to buy Schiff for $34 a share, or about $1.1 billion including net debt, according to Bloomberg. The situation grew interesting when Reckitt Benckiser Group Plc made a surprise offer of $42 a share, or about $1.4 billion.

In a filing with the U.S. Securities and Exchange Commission Bayer said that a competitive bidding process “would result in a price outside Bayer’s set financial criteria.”

Related Market Segments:

blog comments powered by Disqus
  • Natural Sweeteners Spell Success

    Natural Sweeteners Spell Success

    Melissa Kvidahl, Contributing Writer||September 8, 2016
    With so much bad press around sugar, natural sweetener options are gaining momentum.

  • MarketWatch 2016

    MarketWatch 2016

    September 1, 2016
    A roundup of research and market news in the world of wellness.

  • Smart Strategies for Wellness from Within

    Smart Strategies for Wellness from Within

    Marci Clow, MS, RD, Senior Nutritionist, Rainbow Light||September 1, 2016
    Diet and supplements can play a key role in promoting better health.